Exchange Announcement • 31 Jul 2026 15:54
Interim Report on Business Performance (Fair Disclosure)
Exchange Announcement • 29 Jul 2026 11:32
Material Business Matters Related to Investment Decisions(Approval of the Phase 3 Clinical Trial Plan for CKD339, under Development as a Treatment for Hypertension, by the Ministry of Food and Drug Safety (MFDS))
Exchange Announcement • 27 Jul 2026 18:24
Material Business Matters Related to Investment Decisions(ê³ íì ì¹ë£ì ë¡ ê°ë°ì¤ì¸ CKD339ì ìì½ì²(MFDS) ì 3ì ìììí ê³í ì¹ì¸)
Exchange Announcement • 22 Jul 2026 15:21
Implementation and Operation of Compliance Program of the Fair Trade Commission
Exchange Announcement • 30 Jun 2026 09:04